journal article·2024-12-04

Peroxynitrite-Responsive Near-Infrared Fluorescent Imaging Guided Synergistic Chemo-Photodynamic Therapy via Biomimetic Metal–Organic Frameworks

Fangfang Yu, Tingya Wang, Yihan Wang, Liu Liu, Tengfei Liu, Wenyan Yao, Hongjie Xiong, Jiang Xiao, Xiaohui Liu, Hui Jiang, Xuemei Wang

ACS Applied Materials & Interfaces· Volume 16· Issue 48
Publisher page

Abstract

Peroxynitrite (ONOO – ) plays a crucial role in maintaining cellular redox homeostasis and regulating diffusive processes, cellular transport, and signal transduction. Extensive studies have revealed that increased ONOO – levels during tumor progression are associated with heightened levels of oxidative stress. However, current methods lack noninvasive visualization, immediate reporting, and highly sensitive fluorescence sensing. In light of this, we have designed a biomimetic fluorescent nanoplatform, named Z-C-T@CM, for peroxynitrite-responsive near-infrared fluorescent imaging guided cancer treatment. The nanoplatform comprises tetrakis(4-carboxyphenyl) porphyrin (TCPP) and curcumin (CCM) encapsulated within a zeolitic imidazolate framework-8 (ZIF-8), which is coated with a mouse breast cancer cell membrane for enhanced biocompatibility and targeting, while evading immune clearance. In vitro experimental results demonstrate that the as-prepared nanoplatform exhibits enhanced near-infrared fluorescence emission upon exposure to ONOO –, indicating a significant potential for noninvasive in vivo imaging of ONOO – during tumor progression. Additionally, Z-C-T@CM readily degrades in the tumor microenvironment, releasing TCPP and CCM, enabling a synergistic chemo-photodynamic therapy with near-infrared illumination. Further investigations indicate that Z-C-T@CM efficiently stimulates a tumor immune response and facilitates therapeutic efficiency. Collectively, this work introduces a novel noninvasive strategy for ONOO – detection, shedding new light on the integration of cancer diagnosis and efficient treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Metal-Organic Frameworks: Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu 210096, China

Department of Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, PR China

Funding

Jiangsu Provincial Key Research and Development Program · National Key Research and Development Program of China · China Postdoctoral Science Foundation · National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.1073/pnas.87.4.162010.1073/pnas.87.4.1620 ↗
2. 10.1038/320454a010.1038/320454a0 ↗
3. 10.1016/S0891-5849(00)00373-710.1016/S0891-5849(00)00373-7 ↗
4. 10.1074/jbc.M110.16724710.1074/jbc.M110.167247 ↗
5. 10.1038/nrmicro100410.1038/nrmicro1004 ↗
6. 10.1128/IAI.00714-1210.1128/IAI.00714-12 ↗
7. 10.1021/acs.chemrev.7b0056810.1021/acs.chemrev.7b00568 ↗
8. 10.1152/physrev.00029.200610.1152/physrev.00029.2006 ↗
9. 10.1038/nrd222210.1038/nrd2222 ↗
10. 10.1016/j.snb.2022.13139310.1016/j.snb.2022.131393 ↗
11. 10.1002/anie.20210301510.1002/anie.202103015 ↗
12. Cobbs C. S. · Cancer Res. · 2003 · 63 · 8670
13. 10.1016/j.ccr.2021.21435610.1016/j.ccr.2021.214356 ↗
14. 10.1021/acs.analchem.0c0258710.1021/acs.analchem.0c02587 ↗
15. 10.1002/adma.20160121410.1002/adma.201601214 ↗
16. 10.1038/nchem.150010.1038/nchem.1500 ↗
17. 10.1021/acs.analchem.8b0019810.1021/acs.analchem.8b00198 ↗
18. 10.1016/j.snb.2021.13099210.1016/j.snb.2021.130992 ↗
19. 10.1039/C7CS00240H10.1039/C7CS00240H ↗
20. 10.1021/acssensors.0c0155510.1021/acssensors.0c01555 ↗
21. 10.1016/j.ccr.2018.06.01310.1016/j.ccr.2018.06.013 ↗
22. 10.1002/chem.20220082810.1002/chem.202200828 ↗
23. 10.1021/acs.accounts.9b0030210.1021/acs.accounts.9b00302 ↗
24. 10.1021/acs.analchem.2c0357710.1021/acs.analchem.2c03577 ↗
25. 10.1039/C8CC08061E10.1039/C8CC08061E ↗
26. 10.1002/smll.20190273710.1002/smll.201902737 ↗
27. 10.1016/j.bios.2016.10.06010.1016/j.bios.2016.10.060 ↗
28. 10.1038/s41467-022-35721-410.1038/s41467-022-35721-4 ↗
29. 10.1002/adma.20230070010.1002/adma.202300700 ↗
30. 10.1002/adma.20230404610.1002/adma.202304046 ↗
31. 10.1002/adma.20230517110.1002/adma.202305171 ↗
32. 10.1021/acs.inorgchem.8b0131010.1021/acs.inorgchem.8b01310 ↗
33. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
34. 10.1002/anie.20180566410.1002/anie.201805664 ↗
35. 10.1021/cr400532z10.1021/cr400532z ↗
36. 10.1038/nrc90310.1038/nrc903 ↗
37. 10.1073/pnas.060243910310.1073/pnas.0602439103 ↗
38. 10.1039/C7TB02817B10.1039/C7TB02817B ↗
39. 10.1002/adma.20160217310.1002/adma.201602173 ↗
40. 10.1186/s13046-019-1362-110.1186/s13046-019-1362-1 ↗
41. 10.1016/j.cej.2020.12547810.1016/j.cej.2020.125478 ↗
42. 10.1021/acs.chemrev.1c0098010.1021/acs.chemrev.1c00980 ↗
43. 10.1038/nchem.127210.1038/nchem.1272 ↗
44. 10.1039/C7DT02697H10.1039/C7DT02697H ↗
45. 10.1002/adfm.20160405310.1002/adfm.201604053 ↗
46. 10.1021/acs.chemrev.5b0014010.1021/acs.chemrev.5b00140 ↗
47. 10.1021/jacs.6b0911310.1021/jacs.6b09113 ↗
48. 10.1016/j.jphotochemrev.2009.05.00110.1016/j.jphotochemrev.2009.05.001 ↗
49. 10.1016/j.jsbmb.2014.01.00910.1016/j.jsbmb.2014.01.009 ↗
50. 10.1021/mp100455h10.1021/mp100455h ↗
51. 10.7150/thno.457110.7150/thno.4571 ↗
52. 10.1021/acs.analchem.9b0499010.1021/acs.analchem.9b04990 ↗
53. 10.1039/C6CS00192K10.1039/C6CS00192K ↗
54. 10.3390/pharmaceutics1408156410.3390/pharmaceutics14081564 ↗
55. 10.2119/molmed.2015.0008710.2119/molmed.2015.00087 ↗
56. 10.1097/QAD.000000000000207510.1097/QAD.0000000000002075 ↗
57. 10.1007/s10549-011-1647-310.1007/s10549-011-1647-3 ↗